611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

NurseWise 24-Hour Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
Widely Used Antipsychotics May Not Ease Delirium in ICUDisabling Hip Ailment Is Another Health Risk for Obese KidsE-Cigarettes Slowed Wound Healing in Animal Study3-Drug Therapy Might Be Cystic Fibrosis 'Breakthrough'Pounds Regained After Weight-Loss Op Can Tell Your Doc a LotCDC Warns of Polio-Like Virus Striking More U.S. KidsNew Nerve Stimulation Technique Might Relieve Back PainGluten-Free Craze a 'Double-Edged Sword' for Celiac PatientsHealth Tip: Know the Risks of Chicken PoxKids' Concussion Symptoms May Persist for a YearNew DNA-Based Test Approved to Help Verify Blood CompatibilityAHA: A Child's Eyes May Be a Window Into Later Heart Disease RiskGenes, Not Diet, May Be Key to Gout Flare-UpsDiabetes Drug Might Help Shield the Heart From Smog's Ill EffectsHealth Tip: Understanding MigrainesHospital Privacy Curtains May Be Home to Dangerous GermsWeight-Loss Surgery May Raise Gallstone Risk: StudyStudy Sees No Link Between Gout Drug, Kidney DiseaseHealth Tip: Prevent Mold Growth at HomeOne-Third of 'Gluten-Free' Restaurant Foods in U.S. Are Not: StudyHalf of Antibiotics Given Without Infection DiagnosisMediterranean Diet May Help Preserve Your Vision: StudyAHA: Researchers Suggest New Way to Possibly Eliminate Clogged ArteriesCan a 'Noah's Ark' of Microbes Save the World's Health?Brain Scans Suggest Pain of Fibromyalgia Isn't ImaginaryHealth Tip: Treat Your Child's AllergiesAHA: Doctors Could Do More to Help Smokers With Poor CirculationAcne's Stigma Can Take a Big Mental TollDoes Less-Invasive Surgery Make Sense for You?Type 2 Diabetes Tied to Raised Risk of Tumors, Cancer Deaths'Southern' Diet Blamed for Black Americans' Health WoesOne Football Rule Change Might Lower Concussion RiskDeep Space Travel May Damage GI Tract, Animal Study ShowsNew Drug Approved for Antibiotic-Resistant Lung DiseaseDrinking Enough Water Could Be Key to Avoiding UTIsThree New Genes Linked to Chronic Back Pain'Yo-Yo' Cardio Readings May Signal Heart RisksHealth Tip: Understanding Hip Replacement SurgeryCommon Heartburn Drugs Linked to Broken Hips in Dialysis PatientsWith 80,000 Flu Deaths Last Season, Experts Urge VaccinationHealth Tip: Manage Symptoms of AnemiaHealth Tip: Considering LASIK Surgery?Don't Turn a Blind Eye to Vision ProblemsExperimental Vaccine Shows Promise in Preventing TBAntibiotics May Cure Appendicitis -- No Operation NeededGun Victims More Likely to Die Than Other Trauma PatientsSpinal Implant Could Be Breakthrough for Paralyzed PatientsHealth Tip: Maintain Healthy Cholesterol5 Tips to Manage Your Child's AsthmaNew Compounds Might Help Stop Spread of Malaria
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Outcomes for Atrial Fibrillation Similar With Dabigatran, Warfarin


HealthDay News
Updated: Nov 14th 2017

new article illustration

TUESDAY, Nov. 14, 2017 (HealthDay News) -- In clinical practice, patients starting dabigatran therapy do not have significantly different rates of ischemic stroke or extracranial hemorrhage than those starting warfarin therapy, though they have lower rates of intracranial bleeding, according to a study published online Nov. 13 in the Annals of Internal Medicine.

Alan S. Go, M.D., from Kaiser Permanente Northern California in Oakland, and colleagues performed a retrospective cohort study to compare incidence of stroke, bleeding, and myocardial infarction in patients with atrial fibrillation initiating dabigatran or warfarin (n = 25,289 for each) from November 2010 to May 2014.

The researchers found that those receiving dabigatran did not have significantly different rates of ischemic stroke (hazard ratio [HR], 0.92; 95 percent confidence interval [CI], 0.65 to 1.28) or extracranial hemorrhage (HR, 0.89; 95 percent CI, 0.72 to 1.09). However, those initiating dabigatran were less likely to have intracranial bleeding (HR, 0.51; 95 percent CI, 0.33 to 0.79). They were also more likely to have myocardial infarction (HR, 1.88; 95 percent CI, 1.22 to 2.9), but the strength and significance of this association varied in sensitivity analyses and by exposure definition (HR range, 1.13 [95 percent CI, 0.78 to 1.64] to 1.43 [95 percent CI, 0.99 to 2.08). Higher gastrointestinal bleeding rates with dabigatran were seen among older patients and those with kidney disease.

"In matched adults with atrial fibrillation treated in practice, the incidences of stroke and bleeding with dabigatran versus warfarin were consistent with those seen in trials," conclude the authors.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)